Nick Crowe
Dieser Inhalt ist noch nicht in deiner Sprache verfügbar.
Nick Crowe is Chief Operating Officer of Revance. His relevance to the botulinum toxin industry comes from post-acquisition operations for Revance / Crown Laboratories and its aesthetics portfolio, including Daxxify.
Crowe’s role helps separate operational leadership from product-development or science leadership. Revance developed Daxxify before Crown’s 2025 acquisition, while Crowe’s current role is most relevant to the combined company’s operations, supply chain, production, quality, and growth execution.
Role Context
Section titled “Role Context”| Field | Detail |
|---|---|
| Current organization | Revance |
| Current role | Chief Operating Officer |
| Industry relevance | Post-acquisition operations, supply chain, production, and quality context |
| Relevant company | Revance / Crown Laboratories |
| Relevant brand | Daxxify |
| Market context | Current aesthetics portfolio operations after the Crown / Revance integration |
Career Notes
Section titled “Career Notes”- Revance announced Crowe’s promotion to Chief Operating Officer on October 1, 2025.
- Revance described his COO role as covering day-to-day operations, supply chain, production, quality, process streamlining, and strategic initiatives.
- The same announcement described Revance’s aesthetics offerings as including Daxxify, the RHA Collection, SkinPen, MicroPen EVO, ProGen PRP Eclipse, and Biojuve.
- Revance described Crowe as having been with Revance for more than 10 years, most recently as Chief Accounting Officer.
Operations Context
Section titled “Operations Context”Crowe matters because Daxxify is now part of a broader private-company aesthetics and skincare portfolio. Operations, quality, supply-chain, and integration leadership help explain the current company structure without rewriting the product’s earlier Revance Therapeutics development history.
This role should not be used to infer clinical claims. Daxxify remains daxibotulinumtoxinA-lanm, with product-specific labeling, indications, units, and safety language.
Activity and Public Context
Section titled “Activity and Public Context”Crowe’s Revance / Crown and Daxxify relevance is post-acquisition operations context. Thomas Hitchcock, Ph.D. and Conor Gallagher, Ph.D. remain better references for product-science framing, while Steve Kreider anchors revenue leadership.